Modulation of autophagy: a Phase II study of vorinostat plus hydroxychloroquine versus regorafenib in chemotherapy-refractory metastatic colorectal cancer (mCRC).
Sukeshi Patel AroraLaura TennerJohn SarantopoulosJay MorrisQianqian LiuJenny A MendezTyler J CurielJoel MichalekDevalingam MahalingamPublished in: British journal of cancer (2022)
NCT02316340.